Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Amyotrophic Lateral Sclerosis Research, and Systemic Lupus Erythematosus Research.
Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
The nine hole peg test as an outcome measure in progressive MS trials
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis
Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?
MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm
Personalized extended interval dosing of natalizumab in MS
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis
The sequence of structural, functional and cognitive changes in multiple sclerosis
Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
Multiple Sclerosis Data Alliance – A global multi-stakeholder collaboration to scale-up real world data research
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
Predicting clinical progression in multiple sclerosis after 6 and 12 years
Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets
Natural History of Vanishing White Matter
Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS
Comparative utility of disability progression measures in PPMS
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
Recommendations for observational studies of comorbidity in multiple sclerosis
The challenge of comorbidity in clinical trials for multiple sclerosis
The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink